Literature DB >> 23176197

A prolonged ICU stay after interhospital transport?

Joep M Droogh, Maurits H Renes, Jack J M Ligtenberg, Jan G Zijlstra.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23176197      PMCID: PMC3672593          DOI: 10.1186/cc11857

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

Transport of critically ill patients can be complicated [1-3]. Barratt and colleagues studied patients transferred for nonclinical reasons to evaluate the consequences of transportation [4]. There was no difference in mortality but the ICU length of stay (LOS) increased by 3 days, which was explained as a negative impact of the transport on patient physiology. We disagree with this conclusion. First, by including only transports to level 3 ICUs the received level of care for transported patients will increase, introducing a bias. Second, the increase in LOS can be interpreted as a result of selection bias, because patients with a short expected LOS would often not be considered eligible for transport. Also, since there was no increase in mortality, which would have been expected with an increased LOS, we might be looking at a mortality reduction as a result of the transfer to a higher-level ICU. Third, Barrett and colleagues suggest that deterioration of patient physiology during transport is probably responsible for the increase in LOS. However, the reported Intensive Care National Audit and Research Centre scores before and after transport (although not validated for sequential patient assessments) do not support this assumption. Fourth, the method of transportation should have been included in this study. Specialised transport teams deliver patients with a better acute physiology compared with nonspecialised teams [2,5], making a need for regaining physiological stability unlikely. In conclusion, we congratulate Barratt and colleagues for their research. However, we think their conclusion is premature because multiple possible confounders were not taken into account.

Abbreviations

LOS: length of stay.

Competing interests

The authors declare that they have no competing interests.
  5 in total

1.  Comparison of a specialist retrieval team with current United Kingdom practice for the transport of critically ill patients.

Authors:  G Bellingan; T Olivier; S Batson; A Webb
Journal:  Intensive Care Med       Date:  2000-06       Impact factor: 17.440

2.  Inter-hospital transport of critically ill patients; expect surprises.

Authors:  Joep M Droogh; Marije Smit; Jakob Hut; Ronald de Vos; Jack J M Ligtenberg; Jan G Zijlstra
Journal:  Crit Care       Date:  2012-02-12       Impact factor: 9.097

3.  Quality of interhospital transport of the critically ill: impact of a Mobile Intensive Care Unit with a specialized retrieval team.

Authors:  Janke S Wiegersma; Joep M Droogh; Jan G Zijlstra; Janneke Fokkema; Jack J M Ligtenberg
Journal:  Crit Care       Date:  2011-02-28       Impact factor: 9.097

4.  Quality of interhospital transport of critically ill patients: a prospective audit.

Authors:  Jack J M Ligtenberg; L Gert Arnold; Ymkje Stienstra; Tjip S van der Werf; John H J M Meertens; Jaap E Tulleken; Jan G Zijlstra
Journal:  Crit Care       Date:  2005-07-01       Impact factor: 9.097

5.  Effect of non-clinical inter-hospital critical care unit to unit transfer of critically ill patients: a propensity-matched cohort analysis.

Authors:  Helen Barratt; David A Harrison; Kathryn M Rowan; Rosalind Raine
Journal:  Crit Care       Date:  2012-10-03       Impact factor: 9.097

  5 in total
  2 in total

1.  Predictive accuracy of medical transport information for in-hospital mortality.

Authors:  Andrew P Reimer; Jarrod E Dalton
Journal:  J Crit Care       Date:  2017-11-15       Impact factor: 3.425

Review 2.  Transferring the critically ill patient: are we there yet?

Authors:  Joep M Droogh; Marije Smit; Anthony R Absalom; Jack J M Ligtenberg; Jan G Zijlstra
Journal:  Crit Care       Date:  2015-02-20       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.